The emerging approach of this peptide represents a major development in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets multiple pathways – GLP-1 and the GIP hormone – leading https://tirzepatide-peptide061117.targetblogs.com/42323483/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment